LCB-2151
LCB-2151 (Compound 2), a nucleoside analogue, is an anticancer agent. LCB-2151 disrupts the two primary sources of ATP production (glycolysis and mitochondrial oxidative phosphorylation), reducing the bioenergetic capacity of KRAS-mutated pancreatic cancer cells and inducing ROS formation. LCB-2151 effectively inhibits key enzymes (such as CACT and CPT2) in glycolysis, the TCA cycle and fatty acid β-oxidation. LCB-2151 has significant cytotoxicity and induces cells apoptosis. LCB-2151 can be used for radiation therapy of cancers research.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 2211175-99-2
- 分子式: C37H43F8N3O5S2
- 分子量:825.87
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
生物活性
-
化学情報
- 純度とドキュメンテーション
- 参考文献
-
Help & FAQs
生物活性
|
CPT-2 |
化学情報
-
CAS 番号 2211175-99-2
-
分子量 825.87
-
分子式 C37H43F8N3O5S2
-
SMILES
OC[C@@]1(C)C(F)(F)[C@H](N2C(N=C(NC(CC(C)(C)CC[C@@H](SCC3=CC=C(C(F)(F)F)C=C3)CCSCC4=CC=C(C(F)(F)F)C=C4)=O)C=C2)=O)O[C@@H]1CO
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
LCB-2151 関連分類
HY-175673 関連分類
Powered by Bioz
- LCB-2151
- 2211175-99-2
- LCB2151
- LCB 2151
- Carnitine Palmitoyltransferase (CPT)
- Apoptosis
- Oxidative Phosphorylation
- Mitochondrial Metabolism
- Reactive Oxygen Species (ROS)
- Nucleoside analogue
- Anticancer
- Glycolysis
- Mitochondrial
- Oxidative phosphorylation
- TCA cycle,Fatty acid β-oxidation
- Panc-1 cells
- Capan-2 cells
- HepG2 cells
- BxPC3 cells
- Radiation therapy
- Inhibitor
- inhibitor
- inhibit